These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 9346966
1. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, ten Dijke P, Heldin CH. J Biol Chem; 1997 Oct 31; 272(44):28107-15. PubMed ID: 9346966 [Abstract] [Full Text] [Related]
2. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. Abdollah S, Macías-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. J Biol Chem; 1997 Oct 31; 272(44):27678-85. PubMed ID: 9346908 [Abstract] [Full Text] [Related]
4. Identification and characterization of constitutively active Smad2 mutants: evaluation of formation of Smad complex and subcellular distribution. Funaba M, Mathews LS. Mol Endocrinol; 2000 Oct 31; 14(10):1583-91. PubMed ID: 11043574 [Abstract] [Full Text] [Related]
5. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW. Kidney Int; 1999 Oct 31; 56(4):1354-65. PubMed ID: 10504488 [Abstract] [Full Text] [Related]
6. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S, Ericsson J, Nishikawa J, Heldin CH, ten Dijke P. Nucleic Acids Res; 2000 Nov 01; 28(21):4291-8. PubMed ID: 11058129 [Abstract] [Full Text] [Related]
7. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. Osman A, Niles EG, LoVerde PT. J Biol Chem; 2001 Mar 30; 276(13):10072-82. PubMed ID: 11152451 [Abstract] [Full Text] [Related]
8. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II. Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A. Mol Cell Biol; 2000 Nov 30; 20(21):8103-11. PubMed ID: 11027280 [Abstract] [Full Text] [Related]
9. Nuclear targeting of transforming growth factor-beta-activated Smad complexes. Chen HB, Rud JG, Lin K, Xu L. J Biol Chem; 2005 Jun 03; 280(22):21329-36. PubMed ID: 15799969 [Abstract] [Full Text] [Related]
11. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB. EMBO J; 2003 Sep 01; 22(17):4465-77. PubMed ID: 12941698 [Abstract] [Full Text] [Related]
12. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. Prunier C, Pessah M, Ferrand N, Seo SR, Howe P, Atfi A. J Biol Chem; 2003 Jul 11; 278(28):26249-57. PubMed ID: 12732634 [Abstract] [Full Text] [Related]
13. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10669-74. PubMed ID: 9380693 [Abstract] [Full Text] [Related]
14. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. Runyan CE, Schnaper HW, Poncelet AC. J Biol Chem; 2005 Mar 04; 280(9):8300-8. PubMed ID: 15613484 [Abstract] [Full Text] [Related]